Jilin Cheng

1.5k total citations · 1 hit paper
20 papers, 851 citations indexed

About

Jilin Cheng is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jilin Cheng has authored 20 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Jilin Cheng's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (7 papers). Jilin Cheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (7 papers). Jilin Cheng collaborates with scholars based in China, United States and France. Jilin Cheng's co-authors include Shaoping Huang, Jingmao Yang, Xin Cheng, Zhenyu Fan, Zhanju Liu, Cheng Tian, Liping Chen, Yajun Zhang, Jun Li and Liping Chen and has published in prestigious journals such as Clinical Gastroenterology and Hepatology, Oncotarget and Frontiers in Cellular and Infection Microbiology.

In The Last Decade

Jilin Cheng

20 papers receiving 834 citations

Hit Papers

Clinical Features of COVID-19-Related Liver Functional Ab... 2020 2026 2022 2024 2020 200 400 600

Peers

Jilin Cheng
Comparison fields: 5 of 76
  • Infectious Diseases 628
  • Neurology 295
  • Epidemiology 285
  • Surgery 134
  • Hepatology 120
Replace Jingmao Yang with:
Jingmao Yang China
Meaghan Phipps United States
Yajun Zhang China
Xue-hua Li China
Radhika Venugopal India
Dennis R. Wong Netherlands
Antonio Herrero Spain
Vincenzo Messina Italy
Xinguo Zhao China
Jingmao Yang China View profile →
Citations per field, relative to Jilin Cheng
Jilin Cheng · 1×
Citations per year, relative to Jilin Cheng
Jilin Cheng · 1×

Countries citing papers authored by Jilin Cheng

Since Specialization
Citations

This map shows the geographic impact of Jilin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jilin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jilin Cheng more than expected).

Fields of papers citing papers by Jilin Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jilin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jilin Cheng. The network helps show where Jilin Cheng may publish in the future.

Co-authorship network of co-authors of Jilin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jilin Cheng. A scholar is included among the top collaborators of Jilin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jilin Cheng. Jilin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 4
3 11
4 5
5 13
6 11
7 54
8
Clinical Features of COVID-19-Related Liver Functional Abnormality breakdown →
619
9 3
10 5
11 7
12 24
13 12
14 15
15 1
16
Human immunodeficiency virus (HIV) is highly associated with giant idiopathic esophageal ulcers in acquired immunodeficiency syndrome (AIDS) patients.
2
17
The impact of anti-HBV treatment on the occurrence and recurrence of hepatocellular carcinoma: focus on Asian studies.
23
18
HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
15
19
Entecavir promotes CD34⁺ stem cell proliferation in the peripheral blood and liver of chronic hepatitis B and liver cirrhosis patients.
2
20 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026